Commitments and Contingencies (Details) - Schedule of Fair Value of the Founders Shares - Consulting Agreement [Member] |
Mar. 21, 2023
$ / shares
|
|---|---|
| Schedule of Fair Value of the Founders Shares [Line Items] | |
| Share price at grant date (in Dollars per share) | $ 10.15 |
| Risk-free interest rate | 4.62% |
| Remaining life of SPAC (assuming the Extended Date) | 4 months 13 days |
| Share price in no De-SPAC scenario (in Dollars per share) | $ 10.39 |
| Probability of transaction | 50.00% |
| Discount rate | 5.00% |
| X | ||||||||||
- Definition Represents the amount of share price in no De-SPAC scenario. No definition available.
|
| X | ||||||||||
- Definition Probability of transaction. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|